Novel mutations in the GDAP1 gene in patients affected with early-onset axonal Charcot-Marie-Tooth type 4A

2009 ◽  
Vol 19 (7) ◽  
pp. 476-480 ◽  
Author(s):  
Isabella Moroni ◽  
Michela Morbin ◽  
Micaela Milani ◽  
Claudia Ciano ◽  
Marianna Bugiani ◽  
...  
2004 ◽  
Vol 8 (4) ◽  
pp. 221-224 ◽  
Author(s):  
Andrzej Kochański ◽  
Dagmara Kabzińska ◽  
Hanna Drac ◽  
Barbara Ryniewicz ◽  
Katarzyna Rowińska-Marcińska ◽  
...  

1999 ◽  
Vol 14 (5) ◽  
pp. 449-449 ◽  
Author(s):  
Nisrine Bissar-Tadmouri ◽  
Yesim Gulsen-Parman ◽  
Philippe Latour ◽  
Feza Deymeer ◽  
Piraye Serdaroglu ◽  
...  

2008 ◽  
Vol 39 (1) ◽  
pp. 33-38 ◽  
Author(s):  
M. Auer-Grumbach ◽  
C. Fischer ◽  
L. Papić ◽  
E. John ◽  
B. Plecko ◽  
...  

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Beatrice Berti ◽  
Giovanna Longo ◽  
Francesco Mari ◽  
Stefano Doccini ◽  
Ilaria Piccolo ◽  
...  

Abstract Background Charcot-Marie-Tooth disease (CMT) type 4B3 (CMT4B3) is a rare form of genetic neuropathy associated with variants in the MTMR5/SBF1 gene. MTMR5/SBF1 is a pseudophosphatase predicted to regulate endo-lysosomal trafficking in tandem with other MTMRs. Although almost ubiquitously expressed, pathogenic variants primarily impact on the peripheral nervous system, corroborating the involvement of MTMR5/SBF1 and its molecular partners in Schwann cells-mediated myelinization. Case presentation We report a case of severe CMT4B3 characterized by early-onset motor and axonal polyneuropathy in an Italian child in absence of any evidence of brain and spine MRI abnormalities or intellectual disability and with a biochemical profile suggestive of mitochondrial disease. Using an integrated approach combining both NGS gene panels and WES analysis, we identified two novel compound heterozygous missense variants in MTMR5/SBF1 gene, p.R763H (c.2291G > A) and p.G1064E (c.3194G > A). Studies in muscle identified partial defects of oxidative metabolism. Conclusion We describe the first case of an early onset severe polyneuropathy with motor and axonal involvement, due to recessive variants in the MTMR5/SBF1 gene, with no evidence of brain and spine MRI abnormalities, intellectual disability, no clinical and neurophysiological evidences of distal sensory impairment, and rapid neuromuscular deterioration. This report suggests that MTMR5/SBF1 should be considered in cases of infantile-onset CMT with secondary mitochondrial dysfunction.


Author(s):  
Stefano Tozza ◽  
Dario Bruzzese ◽  
Daniele Severi ◽  
Emanuele Spina ◽  
Rosa Iodice ◽  
...  

Abstract Introduction In Charcot-Marie-Tooth type 1A (CMT1A) patients, daily life is mainly influenced by mobility and ambulation dysfunctions. The aim of our work was to evaluate the perception of disturbances that mostly impact on daily life in CMT1A patients and its difference on the basis of age, gender, disability, and quality of life. Methods Forty-one CMT1A patients underwent neurological assessment focused on establishing clinical disability through the Charcot-Marie-Tooth Neuropathy Score (CMTNS) and quality of life through the Short Form-36 (SF-36) questionnaire. We identified from CMT disturbances 5 categories [weakness in lower limbs (WLL), weakness in upper limbs (WUL), skeletal deformities (SD), sensory symptoms (SS), balance (B)] and patients classified the categories from the highest to the lowest impact on daily life (1: highest; 5: lowest). Ranking of the 5 categories, in the overall sample and in the different subgroups (dividing by gender, median of age and disease duration, CMTNS, domains of SF-36), was obtained and differences among subgroups were assessed using a bootstrap approach. Results Rank analysis showed that WLL was the most important disturbance on daily life whereas WUL had the lowest impact. In the older CMT1A group, the most important disturbance on daily life was B that was also the most relevant disturbance in patients with a greater disability. SD influenced daily life in younger patients. SS had less impact on daily life, with the exception of patients with a milder disability. Discussion Our findings demonstrated that the perception of disturbances that mostly impact on CMT1A patients’ daily life changes over the lifetime and with degree of disability.


2021 ◽  
Vol 31 (1) ◽  
pp. 56-68
Author(s):  
Fredrik S. Skedsmo ◽  
Arild Espenes ◽  
Michael A. Tranulis ◽  
Kaspar Matiasek ◽  
Gjermund Gunnes ◽  
...  

2017 ◽  
Vol 25 (2) ◽  
pp. 301-306 ◽  
Author(s):  
S. Tozza ◽  
D. Bruzzese ◽  
C. Pisciotta ◽  
R. Iodice ◽  
M. Esposito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document